Listed by the USPTO as ROMERO, KRISTEN WANG
Tech Center 1600 • Art Units: 1624 1625 1626 1629
This examiner grants 70% of resolved cases
ROMERO, KRISTEN WANG is a Tech Center 1600 examiner assigned to art unit 1624, with 54 resolved cases. The allowance rate is 70.4%, and the median time to allowance is 1161 days. The case volume offers useful initial context, although it is smaller than a mature examiner docket, and the median timeline should be considered in prosecution planning.
The interview lift is 30.8%, suggesting that interviews may assist in moving cases toward allowance. Practitioners may wish to prepare focused interview points while preserving a complete written response. The listed companies are Shanghai Apeiron Therapeutics Company Limited, THE GENERAL HOSPITAL Corporation, and Vanderbilt University. The listed firms are BALLARD SPAHR LLP, ARENTFOX SCHIFF LLP, and BakerHostetler.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18263384 | SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES | Non-Final OA | The General Hospital Corporation |
| 18399675 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER | Non-Final OA | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 18605320 | Compositions of Azadirachta Indica and Methods of Treating Cancer | Non-Final OA | Board of Regents, The University of Texas System |
| 18728949 | ISOCITRATE DEHYDROGENASE 1 INHIBITORS AND METHODS OF USE THEREOF | Non-Final OA | CASE WESTERN RESERVE UNIVERSITY |
| 18615330 | DEVELOPMENT AND OPTIMIZATION OF THIOCHROMENOTHIAZOLE-BASED MSUT2 INHIBITORS AS CANDIDATES FOR THE TREATMENT OF TAUOPATHY | Non-Final OA | The United States Government As Represented By the Department of Veterans Affairs |
| 18719260 | METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF | Non-Final OA | Alexion Pharmaceuticals, Inc. |
| 18688087 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | Non-Final OA | REMIX THERAPEUTICS INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy70.4% of resolved applications examined by Kristen Wang Romero were allowed (54 resolved cases), compared with 54.4% across Art Unit 1624 over the last five years.
This examiner's interview lift is +30.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Kristen Wang Romero took 1,161 days on average from filing to allowance.
Kristen Wang Romero examines applications in Art Unit 1624 in Tech Center 1600 (Biotechnology & Pharmaceuticals).